Wed, August 14, 2024
Tue, August 13, 2024
Mon, August 12, 2024

Michael Ulz Maintained (YMAB) at Sell with Decreased Target to $11 on, Aug 13th, 2024


//stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-11-on-aug-13th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Michael Ulz of Morgan Stanley, Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Sell with Decreased Target from $12 to $11 on, Aug 13th, 2024.

Michael has made no other calls on YMAB in the last 4 months.



There are 2 other peers that have a rating on YMAB. Out of the 2 peers that are also analyzing YMAB, 0 agree with Michael's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michael


  • Justin Walsh of "Jones Trading" Initiated at Strong Buy and Held Target at $23 on, Thursday, July 11th, 2024
  • Nicole Germino of "Truist Securities" Initiated at Strong Buy and Held Target at $21 on, Friday, June 28th, 2024

Publication Contributing Sources